Neuronal IGF‐1 resistance reduces Aβ accumulation and protects against premature death in a model of Alzheimer's disease

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works

A C. elegans mutant that lives twice as long as wild type

Kenyon, C., Chang, J., Gensch, E., Rudner, A., & Tabtiang, R. (1993) · Nature · doi:10.1038/366461a0 · Cited by 3,387 · see citing works

daf-2 , an Insulin Receptor-Like Gene That Regulates Longevity and Diapause in Caenorhabditis elegans

Kimura, K. D., Tissenbaum, H. A., Liu, Y., & Ruvkun, G. (1997) · Science · doi:10.1126/science.277.5328.942 · Cited by 2,250 · see citing works

Role of Brain Insulin Receptor in Control of Body Weight and Reproduction

Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice

Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Géloën, A., Even, P. C., Cervera, P., & Le Bouc, Y. (2003) · Nature · doi:10.1038/nature01298 · Cited by 2,109 · see citing works

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324 · see citing works

Constitutive and regulated α-secretase cleavage of Alzheimer’s amyloid precursor protein by a disintegrin metalloprotease

Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 1,132 · see citing works

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915 · see citing works

Opposing activities protect against age-onset proteotoxicity

Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling

Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine

Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · see citing works

Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 708 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Regulation of C. elegans Life-Span by Insulinlike Signaling in the Nervous System

Wolkow, C. A., Kimura, K. D., Lee, M. S., & Ruvkun, G. (2000) · Science · doi:10.1126/science.290.5489.147 · Cited by 681 · see citing works

A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis

Niedernhofer, L. J., Garinis, G. A., Raams, A., Lalai, A. S., Robinson, A. R., Appeldoorn, E., Odijk, H., Oostendorp, R., Ahmad, A., van Leeuwen, W., et al. (2006) · Nature · doi:10.1038/nature05456 · Cited by 669 · see citing works

Type 2 diabetes mellitus, cognitive impairment and dementia

Stewart, R., & Liolitsa, D. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00027.x · Cited by 562 · see citing works

Evidence for lifespan extension and delayed age–related biomarkers in insulin receptor substrate 1 null mice

Selman, C., Lingard, S., Choudhury, A. I., Batterham, R. L., Claret, M., Clements, M., Ramadani, F., Okkenhaug, K., Schuster, E., Blanc, E., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-9261com · Cited by 532 · see citing works

Brain IRS2 Signaling Coordinates Life Span and Nutrient Homeostasis

Taguchi, A., Wartschow, L. M., & White, M. F. (2007) · Science · doi:10.1126/science.1142179 · Cited by 523 · see citing works

Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia.

Kubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 519 · see citing works

Insulin receptors and insulin action in the brain: review and clinical implications

Schulingkamp, R. J., Pagano, T. C., Hung, D., & Raffa, R. B. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00040-3 · Cited by 491 · see citing works

IRS-2 pathways integrate female reproduction and energy homeostasis

Burks, D. J., de Mora, J. F., Schubert, M., Withers, D. J., Myers, M. G., Towery, H. H., Altamuro, S. L., Flint, C. L., & White, M. F. (2000) · Nature · doi:10.1038/35030105 · Cited by 455 · see citing works

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors

Cukierman‐Yaffe, T., Gerstein, H. C., Williamson, J. D., Lazar, R. M., Lovato, L., Miller, M. E., Coker, L. H., Murray, A. M., Sullivan, M. D., Marcovina, S. M., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1153 · Cited by 452 · see citing works

The Genetics of Aging

Finch, C. E., & Ruvkun, G. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.435 · Cited by 446 · see citing works

Autoradiographic localization of insulin receptors in rat brain: Prominence in olfactory and limbic areas

Hill, J. M., Lesniak, M. A., Pert, C. B., & Roth, J. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90082-5 · Cited by 413 · see citing works

Localization and Characterization of Insulin Receptors in Rat Brain and Pituitary Gland Using in Vitro Autoradiography and Computerized Densitometry*

Werther, G. A., Hogg, A., Oldfield, B. J., McKinley, M. J., Figdor, R., Allen, A. M., & Mendelsohn, F. A. O. (1987) · Endocrinology · doi:10.1210/endo-121-4-1562 · Cited by 334 · see citing works

Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

Matsubara, E., Bryant‐Thomas, T., Pacheco Quinto, J., Henry, T. L., Poeggeler, B., Herbert, D., Cruz‐Sanchez, F., Chyan, Y., Smith, M. A., Perry, G., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01654.x · Cited by 332 · see citing works

Insulin-degrading Enzyme as a Downstream Target of Insulin Receptor Signaling cascade: Implications for Alzheimer's Disease Intervention

Zhao, L., Teter, B., Morihara, T., Lim, G. P., Ambegaokar, S. S., Ubeda, O. J., Frautschy, S. A., & Cole, G. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2860-04.2004 · Cited by 329 · see citing works

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer's disease

de la Monte, S. M., Tong, M., Lester-Coll, N. H., Plater, M. E., & Wands, J. R. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10113 · Cited by 324 · see citing works

Rapid generation of inducible mouse mutants

Seibler, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng012 · Cited by 305 · see citing works

The Emerging Genetic Architecture of Type 2 Diabetes

Doria, A., Patti, M., & Kahn, C. R. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.006 · Cited by 303 · see citing works

Partial Reduction of BACE1 Has Dramatic Effects on Alzheimer Plaque and Synaptic Pathology in APP Transgenic Mice

McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300 · cited 1× · see citing works

Distribution of insulin receptor-like immunoreactivity in the rat forebrain

Unger, J. W., McNeill, T. H., Moxley, R. T., White, M. F., Moss, A., & Livingston, J. N. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90036-5 · Cited by 294 · see citing works

Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism

Kappeler, L., Filho, C. D. D. M., Dupont, J., Leneuve, P., Cervera, P., Périn, L., Loudes, C., Blaise, A., Klein, R., Epelbaum, J., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060254 · Cited by 289 · see citing works

Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways

Stein, T. D., & Johnson, J. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07380.2002 · Cited by 288 · see citing works

Therapy insight, type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease

Haan, M. N. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0124 · Cited by 284 · see citing works

Impaired insulin secretion increases the risk of Alzheimer disease

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240 · see citing works

Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase

Nathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051529 · Cited by 214 · see citing works

Insulin binds to brain blood vessels in vivo

van Houten, M., & Posner, B. I. (1979) · Nature · doi:10.1038/282623a0 · Cited by 180 · see citing works

Molecular connexions between dementia and diabetes

Cole, A. R., Astell, A. J., Green, C., & Sutherland, C. D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.004 · Cited by 161 · see citing works

A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease

Frölich, L., Blum-Degen, D., Riederer, P. F., & Hoyer, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160 · see citing works

Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice

Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1951 · Cited by 158 · see citing works

Dementia: The leading predictor of death in a defined elderly population

Tschanz, J. T., Corcoran, C. M., Skoog, I. G., Khachaturian, A. S., Herrick, J. S., Hayden, K. M., Welsh-Bohmer, K. A., Calvert, T., Norton, M. C., Zandi, P. P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000118210.12660.c2 · Cited by 154 · see citing works

Developmental regulation of energy metabolism in Caenorhabditis elegans

Wadsworth, W. G., & Riddle, D. L. (1989) · Developmental Biology · doi:10.1016/0012-1606(89)90214-5 · Cited by 140 · see citing works

Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice

Meilandt, W. J., Cissé, M., Ho, K., Wu, T. Z., Esposito, L., Scearce-Levie, K. A., Cheng, I. H.-J., Yu, G.-Q., & Mucke, L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2984-08.2009 · Cited by 137 · see citing works

An aging pathway controls the TrkA to p75NTR receptor switch and amyloid β‐peptide generation

Costantini, C., Scrable, H. J., & Puglielli, L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601062 · Cited by 128 · see citing works

Increased Circulating Insulin-like Growth Factor-1 in Late-onset Alzheimer's Disease

Vardy, E. R. L. C., Rice, P. J., Bowie, P. C. W., Holmes, J. D., Grant, P. J., & Hooper, N. M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12401 · Cited by 91 · see citing works

IGF-1-induced Processing of the Amyloid Precursor Protein Family Is Mediated by Different Signaling Pathways

Adlerz, L., Holback, S., Multhaup, G., & Iverfeldt, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611183200 · Cited by 82 · see citing works

Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?

Puglielli, L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 80 · see citing works

Epidermal insulin/IGF‐1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation

Stachelscheid, H., Ibrahim, H., Koch, L., Schmitz, A., Tscharntke, M., Wunderlich, F. T., Scott, J. A., Michels, C., Wickenhauser, C., Haase, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.141 · Cited by 70 · see citing works

Alzheimer's disease could be “type 3 diabetes”

Pilcher, H. R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70434-3 · Cited by 63 · see citing works

Circumventricular Organs: Receptors and Mediators of Direct Peptide Hormone Action on Brain

van Houten, M., & Posner, B. I. (1983) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027310-2.50015-3 · Cited by 62 · see citing works

An inexpensive microcomputer digital imaging system for densitometry: quantitative autoradiography of insulin receptors with 125I and LKB ultrofilm

Baskin, D. G., Davidson, D., Lewellen, T. K., & Graham, M. M. (1986) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(86)90044-0 · Cited by 51 · see citing works

Diabetes and dementia

Lovestone, S. (1999) · Neurology · doi:10.1212/wnl.53.9.1907 · Cited by 42 · see citing works

P1–182: Glycemic control and risk of dementia in a cohort of patients with type 2 diabetes

Whitmer, R. A., Selby, J. V., Eeden, S. K. V. D., Haan, M. N., Quesenberry, C. P., Minkoff, J. R., & Yaffe, K. S. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.557 · Cited by 1 · see citing works

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59903 · Cited by 1,871 · see citing works

Neural mechanisms of ageing and cognitive decline

Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323 · see citing works

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 881 · see citing works

An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers

Bomfim, T. R., Forny‐Germano, L., Sathler, L. B., Brito‐Moreira, J., Houzel, J., Decker, H., Silverman, M. A., Kazi, H., Melo, H. M., McClean, P. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57256 · Cited by 830 · see citing works

Insulin Action in Brain Regulates Systemic Metabolism and Brain Function

Kleinridders, A., Ferris, H. A., Cai, W., & Kahn, C. R. (2014) · Diabetes · doi:10.2337/db14-0568 · Cited by 688 · see citing works

Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease

Nguyen, T. T., Ta, Q., Nguyen, T. K. O., Nguyen, T., & Vo, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093165 · Cited by 338 · see citing works

Protein homeostasis and aging in neurodegeneration

Douglas, P. M., & Dillin, A. G. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201005144 · Cited by 372 · see citing works

Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Akter, K., Lanza, E. A., Martin, S. A., Myronyuk, N., Rua, M., & Raffa, R. B. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03830.x · Cited by 352 · see citing works

Alzheimer’s disease and insulin resistance: translating basic science into clinical applications

Felice, F. G. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 328 · see citing works

Insulin resistance and Parkinson’s disease: A new target for disease modification?

Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works

Insulin in Central Nervous System: More than Just a Peripheral Hormone

Duarte, A. I., Moreira, P. I., & Oliveira, C. R. (2012) · Journal of Aging Research · doi:10.1155/2012/384017 · Cited by 324 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel

Kunkle, B. W., Schmidt, M. A., Klein, H., Naj, A. C., Hamilton‐Nelson, K. L., Larson, E. B., Evans, D. A., Jager, P. L. D., Crane, P. K., Buxbaum, J. D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.3536 · Cited by 254 · see citing works

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Dewanjee, S., Chakraborty, P., Bhattacharya, H., Chacko, L., Singh, B., Chaudhary, A., Javvaji, K., Pradhan, S. R., Vallamkondu, J., Dey, A., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.032 · Cited by 235 · see citing works

Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism

Pilozzi, A. R., Carro, C., & Huang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010338 · Cited by 214 · see citing works

Insulin action at a molecular level – 100 years of progress

White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 214 · see citing works

Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?

Stanley, M., Macauley, S. L., & Holtzman, D. M. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160493 · Cited by 199 · see citing works

Alzheimer’s Disease and Type 2 Diabetes: Multiple Mechanisms Contribute to Interactions

Jayaraman, A., & Pike, C. J. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0476-2 · Cited by 181 · see citing works

Molecular and cellular pathways contributing to brain aging

Zia, A., Pourbagher‐Shahri, A. M., Farkhondeh, T., & Samarghandian, S. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00179-9 · Cited by 186 · see citing works

Toward a comprehensive neurobiology of IGF‐I

Torres‐Alemán, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20778 · Cited by 177 · see citing works

Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood

Lee, S.-H., Zabolotny, J. M., Huang, H., Lee, H., & Kim, Y.-B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.011 · Cited by 176 · see citing works

The new biology of ageing

Partridge, L. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0222 · Cited by 167 · see citing works

Tryptophan metabolism: entering the field of aging and age-related pathologies

van der Goot, A. T., & Nollen, E. A. A. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.007 · Cited by 163 · see citing works

Signaling networks determining life span

Riera, C. E., Merkwirth, C., De Magalhaes Filho, C. D., & Dillin, A. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014451 · Cited by 161 · see citing works

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System

LEWITT, M. S., & Boyd, G. W. (2019) · Biochemistry Insights · doi:10.1177/1178626419842176 · Cited by 160 · see citing works

Insulin-like growth factor receptor signaling regulates working memory, mitochondrial metabolism, and amyloid-β uptake in astrocytes

Logan, S., Pharaoh, G. A., Marlin, M. C., Masser, D. R., Matsuzaki, S., Wronowski, B., Yeganeh, A., Parks, E. E., Premkumar, P., Farley, J. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.013 · Cited by 156 · see citing works

PTEN recruitment controls synaptic and cognitive function in Alzheimer's models

Knafo, S., Sánchez‐Puelles, C., Palomer, E., Delgado, I., Draffin, J. E., Mingo, J., Wahle, T., Kaleka, K. S., Mou, L., Pereda-Pérez, I., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4225 · Cited by 147 · see citing works

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

Pascual‐Lucas, M., da Silva, S. V., Scala, M. D., García, C., González‐Aseguinolaza, G., Mulle, C., Alberini, C. M., Cuadrado‐Tejedor, M., & García‐Osta, A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404228 · Cited by 147 · see citing works

Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

Ezkurdia, A., Ramírez, M. J., & Solas, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054354 · Cited by 153 · see citing works

Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance

Gontier, G., George, C., Chaker, Z., Holzenberger, M., & Aïd, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0343-15.2015 · Cited by 142 · see citing works

Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease

O’Neill, C., Kiely, A. P., Coakley, M. F., Manning, S., & Long-Smith, C. M. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120080 · Cited by 138 · see citing works

Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloidpeptide, insulin signaling, and neuronal function

Takeda, S., Sato, N., Rakugi, H., & Morishita, R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00302f · Cited by 138 · see citing works

IGF-1 Receptor Differentially Regulates Spontaneous and Evoked Transmission via Mitochondria at Hippocampal Synapses

Gazit, N., Vertkin, I., Shapira, I., Helm, M. S., Slomowitz, E., Sheiba, M., Mor, Y., Rizzoli, S. O., & Slutsky, I. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.034 · Cited by 138 · see citing works

FoxO6 regulates memory consolidation and synaptic functionPreprint

Salih, D. A. M., Rashid, A. J., Colas, D., de la Torre-Ubieta, L., Zhu, R. P., Morgan, A. A., Santo, E. E., Ucar, D., Devarajan, K., Cole, C. J., et al. (2012) · Genes & Development · doi:10.1101/gad.208926.112 · Cited by 136 · see citing works

Sleep deprivation exacerbates microglial reactivity and Aβ deposition in a TREM2 -dependent manner in mice

Parhizkar, S., Gent, G., Chen, Y., Rensing, N. R., Gratuze, M., Strout, G. W., Sviben, S., Tycksen, E., Zhang, Q., Erdmann-Gilmore, P., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade6285 · Cited by 134 · see citing works

40 YEARS of IGF1: IGF1: the Jekyll and Hyde of the aging brain

Gubbi, S., Quipildor, G. F., Barzilai, N., Huffman, D. M., & Milman, S. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0093 · Cited by 115 · see citing works

Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer’s disease

Wakabayashi, T., Yamaguchi, K., Matsui, K., Sano, T., Kubota, T., Hashimoto, T., Mano, A., Yamada, K., Matsuo, Y., Kubota, N., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0315-7 · Cited by 116 · see citing works

Single-gene mutations and healthy ageing in mammals

Bartke, A. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0281 · Cited by 107 · see citing works

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease

Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 111 · see citing works

IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease

Sadagurski, M., Cheng, Z., Rozzo, A., Palazzolo, I., Kelley, G. R., Dong, X., Krainc, D., & White, M. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46305 · Cited by 107 · see citing works

Telomere shortening reduces Alzheimer’s disease amyloid pathology in mice

Rolyan, H., Scheffold, A., Heinrich, A., Begus-Nahrmann, Y., Langkopf, B. H., Hölter, S. M., Vogt-Weisenhorn, D. M., Liss, B., Wurst, W., Lie, D. C., et al. (2011) · Brain · doi:10.1093/brain/awr133 · Cited by 106 · see citing works

Tissue‐specific insulin signaling in the regulation of metabolism and aging

Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 100 · see citing works

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Mazucanti, C. H., Cabral‐Costa, J. V., Vasconcelos, A. R., Andreotti, D. Z., Scavone, C., & Kawamoto, E. M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 102 · see citing works

Metabolic Alterations Associated to Brain Dysfunction in Diabetes

Duarte, J. M. N. (2014) · Aging and Disease · doi:10.14336/ad.2014.1104 · Cited by 104 · see citing works

Release of insulin produced by the choroid plexis is regulated by serotonergic signaling

Mazucanti, C. H., Liu, Q.-R., Lang, D., Huang, N., O’Connell, J. F., Camandola, S., & Egan, J. M. (2019) · JCI Insight · doi:10.1172/jci.insight.131682 · Cited by 101 · see citing works

The signaling landscape of insulin-like growth factor 1

Khan, M. Z., Zugaza, J. L., & Torres‐Alemán, I. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108047 · Cited by 106 · see citing works

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review

Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 96 · see citing works

IGF-I and the aging mammalian brain

Piriz, J., Muller, A. P., Trejo, J. L., & Torres‐Alemán, I. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.022 · Cited by 93 · see citing works

The Therapeutic Potential of Insulin-Like Growth Factor-1 in Central Nervous System Disorders

Costales, J. L., & Kolevzon, A. (2016) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.001 · Cited by 93 · see citing works

Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome

Arjunan, A., Sah, D. K., Woo, M., & Song, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00966-z · Cited by 97 · see citing works

IGF-1 receptor antagonism inhibits autophagy

Renna, M., Bento, C. F., Fleming, A., Menzies, F. M., Siddiqi, F. H., Ravikumar, B., Puri, C., Garcı́a-Arencibia, M., Sadiq, O., Corrochano, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt300 · Cited by 89 · see citing works

Agmatine Improves Cognitive Dysfunction and Prevents Cell Death in a Streptozotocin-Induced Alzheimer Rat Model

Song, J., Hur, B. E., Bokara, K. K., Yang, W., Cho, H. J., Park, K. A., Lee, W. T., Lee, K. M., & Lee, J. E. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.3.689 · Cited by 89 · see citing works

Altered longevity‐assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death

Pehar, M., O’Riordan, K. J., Burns‐Cusato, M., Andrzejewski, M. E., del Alcazar, C. R. G., Bürger, C., Scrable, H. J., & Puglielli, L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00547.x · Cited by 85 · see citing works

Central IGF-1 protects against features of cognitive and sensorimotor decline with aging in male mice

Quipildor, G. F., Mao, K., Hu, Z., Novaj, A., Cui, M., Gulinello, M. E., Branch, C. A., Gubbi, S., Patel, K., Moellering, D. R., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00065-3 · Cited by 85 · see citing works

Roles of vascular risk factors in the pathogenesis of dementia

Takeda, S., Rakugi, H., & Morishita, R. (2019) · Hypertension Research · doi:10.1038/s41440-019-0357-9 · Cited by 65 · see citing works

The Alzheimer’s disease transcriptome mimics the neuroprotective signature of IGF-1 receptor-deficient neurons

George, C., Gontier, G., Lacube, P., François, J., Holzenberger, M., & Aïd, S. (2017) · Brain · doi:10.1093/brain/awx132 · Cited by 82 · see citing works

The paradox of neuronal insulin action and resistance in the development of aging‐associated diseases

Steculorum, S. M., Solas, M., & Brüning, J. C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.008 · Cited by 80 · see citing works

A let-7-to-miR-125 MicroRNA Switch Regulates Neuronal Integrity and Lifespan in Drosophila

Chawla, G., Deosthale, P. J., Childress, S., Wu, Y.-C., & Sokol, N. S. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006247 · Cited by 81 · see citing works

Overlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes

Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 80 · see citing works

Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology

Fernandez, A. M., Jiménez, S., Mecha, M., Dávila, D., Guaza, C., Vitórica, J., & Torres‐Alemán, I. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.128 · Cited by 81 · see citing works

IRS2 integrates insulin/ IGF1 signalling with metabolism, neurodegeneration and longevity

White, M. F. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12347 · Cited by 79 · see citing works

Susceptibility to diet-induced obesity and glucose intolerance in the APP SWE/PSEN1 A246E mouse model of Alzheimer’s disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein

Mody, N., Agouni, A., Mcilroy, G. D., Platt, B., & Delibegović, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2160-2 · Cited by 79 · see citing works

Physical Exercise-Induced Myokines in Neurodegenerative Diseases

Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79 · see citing works

Metformin: A Potential Candidate for Targeting Aging Mechanisms

Hu, D., Xie, F., Xiao, Y., Chen, L., Zhong, J., Huang, D., Chen, J., Wei, J., Jiang, Y., & Zhong, T. (2021) · Aging and Disease · doi:10.14336/ad.2020.0702 · Cited by 79 · see citing works

Does Huntingtin play a role in selective macroautophagy?

Steffan, J. S. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12718 · Cited by 77 · see citing works

Brain Alterations and Clinical Symptoms of Dementia in Diabetes: Aβ/Tau-Dependent and Independent Mechanisms

Sato, N., & Morishita, R. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00143 · Cited by 78 · see citing works

Insulin resistance in the brain: An old-age or new-age problem?

Williamson, R., McNeilly, A. D., & Sutherland, C. D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.05.007 · Cited by 77 · see citing works

The problem of genotype and sex differences in life expectancy in transgenic AD mice

Rae, E. A., & Brown, R. E. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.002 · Cited by 75 · see citing works

Aging and the aggregating proteome

David, D. C. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00247 · Cited by 74 · see citing works

Metformin treatment ameliorates diabetes‐associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1

Tanokashira, D., Kurata, E., Fukuokaya, W., Kawabe, K., Mana, K., Takeuchi, H., Nakazato, M., & Taguchi, A. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12436 · Cited by 76 · see citing works

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease

Stöhr, O., Schilbach, K., Moll, L., Hettich, M. M., Freude, S., Wunderlich, F. T., Ernst, M. B., Zemva, J., Brüning, J. C., Krone, W., et al. (2011) · AGE · doi:10.1007/s11357-011-9333-2 · Cited by 73 · see citing works

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice

Hiltunen, M. O., Khandelwal, V. K. M., Yaluri, N., Tiilikainen, T., Tusa, M., Koivisto, H., Krzisch, M., Vepsäläinen, S., Mäkinen, P. M., Kemppainen, S., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01384.x · Cited by 72 · see citing works

Mammalian models of extended healthy lifespan

Selman, C., & Withers, D. J. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0243 · Cited by 71 · see citing works

Progression of Alzheimer’s disease, tau propagation, and its modifiable risk factors

Takeda, S. (2018) · Neuroscience Research · doi:10.1016/j.neures.2018.08.005 · Cited by 71 · see citing works

Genome maintenance and transcription integrity in aging and disease

Wolters, S., & Schumacher, B. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00019 · Cited by 69 · see citing works

Molecular and cellular aspects of age-related cognitive decline and Alzheimer’s disease

Hullinger, R., & Puglielli, L. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.008 · Cited by 68 · see citing works

State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease

Rhea, E. M., Leclerc, M., Yassine, H. N., Capuano, A. W., Tong, H., Petyuk, V. A., Macauley, S. L., Fioramonti, X., Carmichael, O., Calon, F., et al. (2023) · Aging and disease · doi:10.14336/ad.2023.0814 · Cited by 70 · see citing works

Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies

Miao, J., Zhang, Y., Chen, S., Zheng, Q., & Guo, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04457-1 · Cited by 66 · see citing works

Ageing and protein aggregation-mediated disorders: from invertebrates to mammals

Dillin, A. G., & Cohen, E. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0271 · Cited by 62 · see citing works

Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors

Sato, N., & Morishita, R. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00064 · Cited by 63 · see citing works

Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease

Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A. E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 60 · see citing works

Role of Insulin Signaling in the Interaction Between Alzheimer Disease and Diabetes Mellitus: A Missing Link to Therapeutic Potential

Sato, N., Takeda, S., Uchio‐Yamada, K., Ueda, H., Fujisawa, T., Rakugi, H., & Morishita, R. (2011) · Current Aging Science · doi:10.2174/1874609811104020118 · Cited by 61 · see citing works

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer’s Disease

Ostrowski, P. P., Barszczyk, A., Forstenpointner, J., Zheng, W., & Feng, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155733 · Cited by 60 · see citing works

Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease

Taguchi, A., Tanokashira, D., & Fukuokaya, W. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253535 · Cited by 59 · see citing works

Alzheimer Amyloid Peptide Aβ42 Regulates Gene Expression of Transcription and Growth Factors

Barucker, C., Sommer, A., Beckmann, G., Eravci, M., Harmeier, A., Schipke, C. G., Brockschnieder, D., Dyrks, T., Althoff, V., Fraser, P. E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141902 · Cited by 58 · see citing works

Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans

Keowkase, R., Aboukhatwa, M. A., & Luo, Y. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.008 · Cited by 58 · see citing works

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study

Hertze, J., Nägga, K., Minthon, L., & Hansson, O. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-64 · Cited by 58 · see citing works

Mechanisms Underlying Brain Aging Under Normal and Pathological Conditions

Jin, M., & Cai, S. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00969-9 · Cited by 59 · see citing works

Neurotrophins and Other Growth Factors in the Pathogenesis of Alzheimer’s Disease

Numakawa, T., & Kajihara, R. (2023) · Life · doi:10.3390/life13030647 · Cited by 57 · see citing works

Insulin growth factor binding protein 7 is a novel target to treat dementia

Agbemenyah, H. Y., Agís‐Balboa, R. C., Burkhardt, S., Delalle, I., & Fischer, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.011 · Cited by 55 · see citing works

High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status

Takalo, M., Haapasalo, A., Martiskainen, H., Kurkinen, K. M. A., Koivisto, H., Miettinen, P., Khandelwal, V. K. M., Kemppainen, S., Kamińska, D., Mäkinen, P. M., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.003 · Cited by 54 · see citing works

Emergence and natural selection of drug-resistant prions

Shorter, J. (2010) · Molecular BioSystems · doi:10.1039/c004550k · Cited by 52 · see citing works

Impaired Insulin Signaling and Mechanisms of Memory Loss

Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 51 · see citing works

IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model

Sohrabi, M., Floden, A. M., Manocha, G. D., Klug, M. G., & Combs, C. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00200 · Cited by 49 · see citing works

High insulinlike growth factor I is associated with cognitive decline in Huntington disease

Saleh, N., Moutereau, S., Azulay, J., Verny, C., Simonin, C., Tranchant, C., Hawajri, N. E., Bachoud‐Lévi, A., & Maison, P. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e62076 · Cited by 48 · see citing works

Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression

Xia, Y., Qadota, H., Wang, Z.-H., Liu, P., Liu, X., Ye, K. X., Matheny, C. J., Berglund, K., Yu, S. P., Drake, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8658 · Cited by 46 · see citing works

The intersection between growth factors, autophagy and ER stress: A new target to treat neurodegenerative diseases?

García-Huerta, P., Troncoso-Escudero, P., Jerez, C., Hetz, C. A., & Vidal, R. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.052 · Cited by 47 · see citing works

Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice

Jayarathne, H. S. M., Debarba, L. K., Jaboro, J. J., Ginsburg, B. C., Miller, R. A., & Sadagurski, M. (2022) · Aging Cell · doi:10.1111/acel.13653 · Cited by 45 · see citing works

Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin

Filho, C. D. D. M., Kappeler, L., Dupont, J., Solinc, J., Villapol, S., Denis, C., Nosten‐Bertrand, M., Billard, J., Blaise, A., Tronche, F., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15626718 · Cited by 45 · see citing works

Diabetes and neurodegeneration in the brain

Toth, C. C. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00035-7 · Cited by 46 · see citing works

O1‐03‐08: Neuronal IGF‐1 resistance protects against premature death and reduces β‐Amyloid accumulation in Tg2576 mice

Hettich, M. M., Freude, S., Stöhr, O., Udelhoven, M., Krone, W., & Schubert, M. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.212

Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease

Stöhr, O., Schilbach, K., Moll, L., Hettich, M. M., Freude, S., Wunderlich, F. T., Ernst, M. B., Zemva, J., Brüning, J. C., Krone, W., et al. (2011) · AGE · doi:10.1007/s11357-011-9333-2 · Cited by 73 · see citing works

Neuronale IGF-1 Resistenz reduziert die β-Amyloid Akkumulation und schützt vor Alzheimer assoziierten Letalität in vivo

Hettich, M., Stöhr, O., Leeser, U., Udelhoven, M., Koch, L., Brüning, J., Krone, W., & Schubert, M. (2009) · Diabetologie und Stoffwechsel · doi:10.1055/s-0029-1221880

Role of neuronal IGF-1R signaling for the pathogenesis of Alzheimer's disease

Hettich, M. M. (2009) · Kölner Universitäts PublikationsServer (Universität zu Köln)

P2‐249: Neuronal insulin resistance reduces Alzheimer‐like pathology in Tg2576 mice independent of Foxo1 mediated transcription

Moll, L., Schilbach, K., Stöhr, O., Udelhoven, M., Zemva, J., Freude, S., Brüning, J. C., Krone, W., & Schubert, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.1132